Lia Bally
15
2
3
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery
Role: lead
How Altered Gut-Brain-Axis Influences Food Choices: Part 2 (BrainFood)
Role: lead
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes
Role: lead
Supporting Meal Management in Type 1 Diabetes
Role: lead
Forecasting and Preventing Post-Bariatric Hypoglycaemia WP 3
Role: lead
A Personal Nutrition Advisor to Assist Remote Dietary Counselling for Weight Loss and Maintenance
Role: lead
Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)
Role: lead
Simplified Meal Approach Using Hybrid Closed-loop Insulin Delivery in Youth and Young Adults With Type 1 Diabetes
Role: lead
Forecasting and Preventing Post-Bariatric Hypoglycaemia WP 1
Role: lead
Forecasting and Preventing Post-Bariatric Hypoglycaemia WP 2
Role: lead
How Altered Gut-Brain-Axis Influences Food Choices: Part 1
Role: lead
Evaluation of the Neuro-endocrine Response to Post-prandial Hyperinsulinaemic Hypoglycaemia.
Role: lead
Fostering Exercise After Bariatric Surgery
Role: lead
Effect of Postprandial Hyperinsulinaemic Hypoglycaemia on Driving Performance.
Role: lead
Assessing Insulin Turnover Using an In-vivo Deuterated Water Experiment.
Role: lead
All 15 trials loaded